ARDS (Aridis Pharmaceuticals) Beginning Cash Position: $0.52 Mil (As of Sep. 2023)


ARDS Aridis Pharmaceuticals Inc ARDS
12 GF Score
Price $0.00
View Full Analysis

What is Aridis Pharmaceuticals Beginning Cash Position?

Aridis Pharmaceuticals ARDS -99.00% 12 Beginning Cash Position is $0.52 Mil as of Sep. 2023. GuruFocus rates ARDS with a GF Score™ of 12/100.

Aridis Pharmaceuticals's Beginning Cash Position for the quarter that ended in Sep. 2023 was $0.52 Mil.

Aridis Pharmaceuticals's quarterly Beginning Cash Position declined from Mar. 2023 ($5.56 Mil) to Jun. 2023 ($1.82 Mil) and declined from Jun. 2023 ($1.82 Mil) to Sep. 2023 ($0.52 Mil).

Aridis Pharmaceuticals's annual Beginning Cash Position declined from Dec. 2020 ($20.90 Mil) to Dec. 2021 ($8.73 Mil) but then increased from Dec. 2021 ($8.73 Mil) to Dec. 2022 ($19.99 Mil).

Aridis Pharmaceuticals Beginning Cash Position Related Terms

Aridis Pharmaceuticals Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Aridis Pharmaceuticals's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aridis Pharmaceuticals Beginning Cash Position Chart

Aridis Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Beginning Cash Position
Get a 7-Day Free Trial 25.10 24.24 20.90 8.73 19.99

Aridis Pharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.95 3.13 5.56 1.82 0.52
ARDS
12GF Score
Aridis Pharmaceuticals Inc ARDS
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aridis Pharmaceuticals Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $0.52 Mil mean?
Aridis Pharmaceuticals (ARDS) has a Beginning Cash Position of $0.52 Mil as of Sep. 2023. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Aridis Pharmaceuticals and its competitors.
Is Aridis Pharmaceuticals' Beginning Cash Position too high?
Aridis Pharmaceuticals' current Beginning Cash Position is $0.52 Mil. Overall, Aridis Pharmaceuticals has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Aridis Pharmaceuticals' Beginning Cash Position compare to ARTL and REVB?
Aridis Pharmaceuticals' Beginning Cash Position of $0.52 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Aridis Pharmaceuticals and its competitors. Aridis Pharmaceuticals's current Beginning Cash Position is $0.52 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aridis Pharmaceuticals stock overvalued right now?
Aridis Pharmaceuticals (ARDS) has a current Beginning Cash Position of $0.52 Mil. The current Beginning Cash Position is $0.52 Mil. Aridis Pharmaceuticals' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Aridis Pharmaceuticals (ARDS), the current Beginning Cash Position is $0.52 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aridis Pharmaceuticals Business Description

Address 983 University Avenue, Building B, Los Gatos, CA, USA, 95032
Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.
12GF Score

Get the complete analysis for ARDS

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price